PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Last trade$48.40
Day change-$0.60 (-1.22%)
Day range$48.26 – $49.45
Volume190,405
Market cap$7.78B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$7.78B
Price / earnings
28.02×
Price / book
6.41×
Price / sales
1.36×
EV / sales
1.39×
EV / EBITDA
15.95×
Profitability
Earnings per share
$1.75
Return on assets
4.69%
Return on equity
22.86%
Dividend yield
0.59%
Liquidity and leverage
Debt / equity
0.22×
Current ratio
0.8×
Quick ratio
0.8×
Cash ratio
0.1×
Cash flow
Price / cash flow
13.42×
Price / free cash flow
942.72×
Free cash flow
$8.25M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for PACS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.5B
$1.43B
$1.42B
$1.36B
$1.34B
$1.31B
$1.28B
$1.21B
Cost of revenue
$1.14B
$1.18B
$1.07B
$1.04B
$1.05B
$1.12B
$1.02B
$949.35M
Gross profit
$356.43M
$243.76M
$345.96M
$319.22M
$298.31M
$194.01M
$253.36M
$258.54M
Selling, general and administrative
$138.41M
$114.31M
$112.32M
$113.49M
$102.53M
$100.33M
$98.72M
$89.64M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$256.71M
$134.43M
$225.92M
$224.53M
$212.04M
$113.51M
$205.22M
$186.56M
Operating income
$99.72M
$109.33M
$120.04M
$94.69M
$86.27M
$80.5M
$48.14M
$71.98M
Interest expense
-$5.1M
-$6.04M
-$6.42M
-$8.58M
-$8.53M
-$4.35M
-$6.9M
-$9.3M
Income before taxes
$91.31M
$105.84M
$113.74M
$86.81M
$76.3M
$78.61M
$42.73M
$61.2M
Income taxes
$30.5M
$29.49M
$33.07M
$27.03M
$23.97M
$27.65M
$14.35M
$25.01M
Net income
$60.81M
$76.35M
$80.67M
$59.79M
$52.33M
$50.97M
$28.38M
$36.19M
Net income attributable to common shareholders
$60.82M
$76.37M
$80.7M
$59.7M
$52.41M
$50.96M
$28.47M
$37.2M
EBITDA
$119.8M
$129.45M
$138.11M
$110.07M
$100.67M
$93.68M
$60.85M
$84.9M
Basic earnings per share
$0.38
$0.48
$0.51
$0.38
$0.33
$0.33
$0.18
$0.24
Diluted earnings per share
$0.37
$0.47
$0.50
$0.46
$0.32
$0.31
$0.17
$0.24
Recent news
Company coverage with links to the original publishers.
PACS Group, Inc. reported Q3 2026 earnings of $0.63 per share, beating consensus estimates of $0.56 and showing year-over-year growth from $0.32. Revenue reached $1.5 billion, surpassing estimates by 3.09%. The stock has gained 18.7% year-to-date, outperforming the S&P 500's 10.2% gain. However, the company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.
Medpace (MEDP) reported Q3 2026 earnings of $4.84 per share, beating consensus estimates of $4.45, with revenues of $716 million exceeding expectations by 1.02%. However, the stock has underperformed the S&P 500 year-to-date, gaining 10.8% versus the market's 12.7%. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Medical Services industry ranks in the bottom 34% of Zacks industries.
PACS Group shares jumped 6.2% to $47.75 on investor optimism ahead of Q3 2026 earnings release. The company is expected to report 75% earnings growth and 8.1% revenue growth. However, with unchanged consensus EPS estimates over the past 30 days, analysts caution that the stock may lack momentum for sustained gains without positive estimate revisions.
PACS Group announced definitive agreements to acquire operations of 32 skilled nursing facilities across Florida with 4,049 licensed beds from Omega Healthcare Investors subsidiaries. The transaction, expected to close in Q4 2026, expands PACS's presence in the high-growth post-acute care market and establishes a statewide network in Florida. The acquisition complements PACS's existing Southern footprint across Texas, South Carolina, Tennessee, and Kentucky.
Ensign Group (ENSG) is benefiting from rising occupancy, patient volumes, and skilled-mix revenue growth in the post-acute care market. The company completed 25 acquisitions in H1 2026, adding 3,109 beds, and its Standard Bearer real estate segment generated $44.1 million in rental revenues. With a Zacks Rank #2 (Buy) rating and raised 2026 EPS guidance to $7.75-$7.85, ENSG faces headwinds from government reimbursement risks and rising expense growth.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.